Home LiteratureArticle Details
PMID: 10402464 Published · ppublish English Journal Article

Intracellular localization of proteasomal degradation of a viral antigen.

The Journal of cell biology ·Vol. 146 ·No. 1 ·1999-07-12 ·Pages 113-24

Antón LC, Schubert U, Bacík I, Princiotta MF, Wearsch PA, Gibbs J, Day PM, Realini C, Rechsteiner MC, Bennink JR, Yewdell JW

Abstract

To better understand proteasomal degradation of nuclear proteins and viral antigens we studied mutated forms of influenza virus nucleoprotein (NP) that misfold and are rapidly degraded by proteasomes. In the presence of proteasome inhibitors, mutated NP (dNP) accumulates in highly insoluble ubiquitinated and nonubiquitinated species in nuclear substructures known as promyelocytic leukemia oncogenic domains (PODs) and the microtubule organizing center (MTOC). Immunofluorescence revealed that dNP recruits proteasomes and a selective assortment of molecular chaperones to both locales, and that a similar (though less dramatic) effect is induced by proteasome inhibitors in the absence of dNP expression. Biochemical evidence is consistent with the idea that dNP is delivered to PODs/MTOC in the absence of proteasome inhibitors. Restoring proteasome activity while blocking protein synthesis results in disappearance of dNP from PODs and the MTOC and the generation of a major histocompatibility complex class I-bound peptide derived from dNP but not NP. These findings demonstrate that PODs and the MTOC serve as sites of proteasomal degradation of misfolded dNP and probably cellular proteins as well, and imply that antigenic peptides are generated at one or both of these sites.

MeSH Terms
Antigen Presentation/drug effects Antigens, Viral/chemistry,genetics,immunology,metabolism Canavanine/pharmacology Centrosome/drug effects,enzymology,metabolism Cysteine Endopeptidases/metabolism Enzyme Inhibitors/pharmacology Fluorescent Antibody Technique Histocompatibility Antigens Class I/chemistry,genetics,immunology,metabolism Humans Leupeptins/pharmacology Molecular Chaperones/metabolism Multienzyme Complexes/metabolism Mutation Nucleocapsid Proteins Nucleoproteins Orthomyxoviridae Osmolar Concentration Peptide Fragments/chemistry,genetics,immunology,metabolism Proteasome Endopeptidase Complex Protein Biosynthesis Protein Conformation/drug effects Protein Folding Solubility Tumor Cells, Cultured Ubiquitins/metabolism Viral Core Proteins/chemistry,genetics,immunology,metabolism
Chemicals
Antigens, Viral Enzyme Inhibitors Histocompatibility Antigens Class I Leupeptins Molecular Chaperones Multienzyme Complexes Nucleocapsid Proteins Nucleoproteins Peptide Fragments Ubiquitins Viral Core Proteins Canavanine Cysteine Endopeptidases Proteasome Endopeptidase Complex benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Antón L C
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.
Schubert U
Bacík I
Princiotta M F
Wearsch P A
Gibbs J
Day P M
Realini C
Rechsteiner M C
Bennink J R
Yewdell J W
References (38)
38 references, click to expand
  1. Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome.
    Eur J Cell Biol. 1996 Nov;71(3):311-8 PMID: 8929570
  2. Antigen processing and presentation by the class I major histocompatibility complex.
    Annu Rev Immunol. 1996;14:369-96 PMID: 8717519
  3. Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70.
    J Biol Chem. 1997 Apr 4;272(14):9002-10 PMID: 9083024
  4. Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.
    Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3978-83 PMID: 9108090
  5. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody.
    Immunity. 1997 Jun;6(6):715-26 PMID: 9208844
  6. Proteasome inhibitors and antigen presentation.
    Biopolymers. 1997;43(4):269-80 PMID: 9316392
  7. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.
    Nature. 1997 Oct 30;389(6654):971-4 PMID: 9353120
  8. SUMO-1: wrestling with a new ubiquitin-related modifier.
    Trends Biochem Sci. 1997 Oct;22(10):374-6 PMID: 9357311
  9. Dynamics of proteasome distribution in living cells.
    EMBO J. 1997 Oct 15;16(20):6087-94 PMID: 9321388
  10. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Biochemistry. 1997 Nov 25;36(47):14418-29 PMID: 9398160
  11. Nuclear dots: actors on many stages.
    Immunobiology. 1997 Dec;198(1-3):307-31 PMID: 9442402
  12. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
    J Immunol. 1998 May 15;160(10):4859-68 PMID: 9590233
  13. Mechanisms of MHC class I--restricted antigen processing.
    Annu Rev Immunol. 1998;16:323-58 PMID: 9597133
  14. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Nat Genet. 1998 Jun;19(2):148-54 PMID: 9620770
  15. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.
    J Virol. 1998 Aug;72(8):6581-91 PMID: 9658103
  16. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Mol Cell. 1998 Aug;2(2):233-9 PMID: 9734360
  17. Proteasome inhibitors: valuable new tools for cell biologists.
    Trends Cell Biol. 1998 Oct;8(10):397-403 PMID: 9789328
  18. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation.
    Nature. 1998 Nov 26;396(6709):373-6 PMID: 9845074
  19. Aggresomes: a cellular response to misfolded proteins.
    J Cell Biol. 1998 Dec 28;143(7):1883-98 PMID: 9864362
  20. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitin-specific protease contributes to its roles in the activation of gene expression and stimulation of virus replication.
    J Virol. 1999 Jan;73(1):417-26 PMID: 9847347
  21. Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase.
    J Virol. 1999 Jan;73(1):650-7 PMID: 9847370
  22. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
    J Cell Biol. 1998 Dec 14;143(6):1457-70 PMID: 9852144
  23. The ubiquitin-proteasome pathway: on protein death and cell life.
    EMBO J. 1998 Dec 15;17(24):7151-60 PMID: 9857172
  24. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  25. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  26. Expression of influenza A virus internal antigens on the surface of infected P815 cells.
    J Immunol. 1981 May;126(5):1814-9 PMID: 7217668
  27. Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen.
    Virology. 1983 Jul 30;128(2):319-30 PMID: 6310860
  28. Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ.
    J Cell Biol. 1984 May;98(5):1886-94 PMID: 6725403
  29. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
    Mol Cell Biol. 1985 Dec;5(12):3403-9 PMID: 3939316
  30. Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.
    J Exp Med. 1988 Oct 1;168(4):1211-24 PMID: 2459295
  31. PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
    Blood. 1993 Sep 15;82(6):1858-67 PMID: 8400236
  32. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein.
    Cell. 1994 Jan 28;76(2):333-43 PMID: 8293467
  33. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
    Cell. 1994 Jan 28;76(2):345-56 PMID: 8293468
  34. KEKE motifs. Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors.
    FEBS Lett. 1994 Jul 11;348(2):109-13 PMID: 8034024
  35. Production and characterization of monoclonal antibodies specific to multi-ubiquitin chains of polyubiquitinated proteins.
    FEBS Lett. 1994 Aug 1;349(2):173-80 PMID: 7519568
  36. Human proteasomes analysed with monoclonal antibodies.
    Biochem J. 1995 Jan 1;305 ( Pt 1):245-52 PMID: 7826336
  37. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
    Cancer Res. 1996 Jul 1;56(13):2945-8 PMID: 8674046
  38. The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal.
    J Virol. 1997 Mar;71(3):1850-6 PMID: 9032315
Article Info
Journal
The Journal of cell biology
Abbr.
J Cell Biol
ISSN
0021-9525
Published
1999-07-12
Pages
113-24
Language
English
Region
United States
NLM ID
0375356
PMCID
PMC2199725
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com